DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,323,000 | +2.5% | 8,992 | +0.6% | 0.19% | +9.0% |
| Q2 2022 | $2,267,000 | -10.9% | 8,942 | +3.1% | 0.18% | +11.2% |
| Q1 2022 | $2,543,000 | -13.5% | 8,669 | -3.0% | 0.16% | +0.6% |
| Q4 2021 | $2,939,000 | +8.6% | 8,933 | +0.5% | 0.16% | -1.9% |
| Q3 2021 | $2,706,000 | +12.4% | 8,888 | -0.9% | 0.16% | +11.7% |
| Q2 2021 | $2,407,000 | +22.4% | 8,968 | +2.6% | 0.14% | +10.7% |
| Q1 2021 | $1,967,000 | -6.4% | 8,738 | -7.7% | 0.13% | -11.5% |
| Q4 2020 | $2,102,000 | +2.8% | 9,462 | -0.3% | 0.15% | -11.4% |
| Q3 2020 | $2,044,000 | +20.4% | 9,494 | -1.1% | 0.17% | +6.4% |
| Q2 2020 | $1,698,000 | +33.7% | 9,604 | +4.7% | 0.16% | +4.7% |
| Q1 2020 | $1,270,000 | +10.0% | 9,174 | +21.9% | 0.15% | +22.0% |
| Q4 2019 | $1,155,000 | +3.5% | 7,524 | -2.6% | 0.12% | -3.1% |
| Q3 2019 | $1,116,000 | +1.1% | 7,724 | 0.0% | 0.13% | -3.1% |
| Q2 2019 | $1,104,000 | +8.2% | 7,724 | 0.0% | 0.13% | +4.0% |
| Q1 2019 | $1,020,000 | +21.4% | 7,724 | -5.2% | 0.13% | +4.1% |
| Q4 2018 | $840,000 | -5.1% | 8,149 | 0.0% | 0.12% | +4.3% |
| Q3 2018 | $885,000 | +10.1% | 8,149 | 0.0% | 0.12% | +3.6% |
| Q2 2018 | $804,000 | -2.8% | 8,149 | -3.6% | 0.11% | -5.9% |
| Q1 2018 | $827,000 | +5.5% | 8,449 | 0.0% | 0.12% | +2.6% |
| Q4 2017 | $784,000 | +9.7% | 8,449 | +1.4% | 0.12% | +5.5% |
| Q3 2017 | $715,000 | +1.7% | 8,335 | 0.0% | 0.11% | +8.9% |
| Q2 2017 | $703,000 | +0.9% | 8,335 | +2.3% | 0.10% | -2.9% |
| Q1 2017 | $697,000 | +9.9% | 8,150 | 0.0% | 0.10% | +6.1% |
| Q4 2016 | $634,000 | -11.7% | 8,150 | -11.0% | 0.10% | -9.3% |
| Q3 2016 | $718,000 | -19.7% | 9,160 | +3.5% | 0.11% | -23.4% |
| Q2 2016 | $894,000 | +6.4% | 8,850 | 0.0% | 0.14% | +16.5% |
| Q1 2016 | $840,000 | +2.2% | 8,850 | 0.0% | 0.12% | 0.0% |
| Q4 2015 | $822,000 | +9.0% | 8,850 | 0.0% | 0.12% | -4.7% |
| Q3 2015 | $754,000 | -0.4% | 8,850 | 0.0% | 0.13% | +7.6% |
| Q2 2015 | $757,000 | +0.8% | 8,850 | 0.0% | 0.12% | +0.9% |
| Q1 2015 | $751,000 | -50.5% | 8,850 | -50.0% | 0.12% | -11.4% |
| Q4 2014 | $1,518,000 | +12.9% | 17,700 | 0.0% | 0.13% | +6.5% |
| Q3 2014 | $1,344,000 | -3.6% | 17,700 | 0.0% | 0.12% | -5.3% |
| Q2 2014 | $1,394,000 | +5.0% | 17,700 | 0.0% | 0.13% | 0.0% |
| Q1 2014 | $1,328,000 | +34.8% | 17,700 | +38.7% | 0.13% | -16.0% |
| Q4 2013 | $985,000 | +28.9% | 12,758 | +15.7% | 0.16% | +25.8% |
| Q3 2013 | $764,000 | +10.1% | 11,023 | +0.6% | 0.12% | +2.5% |
| Q2 2013 | $694,000 | – | 10,958 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |